Your browser doesn't support javascript.
loading
Impact of peripheral anterior synechiae on the outcome of combined phacoemulsification, goniosynechialysis and goniotomy for primary angle-closure glaucoma and cataract: a multicenter observational study.
Lin, Fengbin; Zhang, Yingzhe; Zhu, Xiaomin; Yu, Ping; Fan, Sujie; Lv, Aiguo; Li, Xiaoyan; Tang, Li; Zhang, Yao; Tang, Guangxian; Yan, Xiaowei; Lu, Lan; Xiao, Meichun; Yuan, Huiping; Song, Wulian; Zhou, Minwen; Zhao, Xiaohuan; Nie, Xin; Liao, Mengfei; Song, Yunhe; Wang, Zhenyu; Chen, Weirong; Barton, Keith; Park, Ki Ho; Aung, Tin; Lam, Dennis S C; Weinreb, Robert N; Tham, Clement C; Zeng, Liuzhi; Xie, Lin; Wang, Ningli; Zhang, Xiulan.
Afiliação
  • Lin F; State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou 510060, China.
  • Zhang Y; State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou 510060, China.
  • Zhu X; Department of Ophthalmology, the Third Affiliated Hospital of Chongqing Medical University, Chongqing 401120, China.
  • Yu P; Department of Ophthalmology, Chengdu First People's Hospital, Chengdu 610095, China.
  • Fan S; Handan City Eye Hospital (The Third Hospital of Handan), Handan 056001, China.
  • Lv A; Handan City Eye Hospital (The Third Hospital of Handan), Handan 056001, China.
  • Li X; Handan City Eye Hospital (The Third Hospital of Handan), Handan 056001, China.
  • Tang L; Department of Ophthalmology, West China Hospital of Sichuan University, Chengdu 610041, China.
  • Zhang Y; Department of Ophthalmology, West China Hospital of Sichuan University, Chengdu 610041, China.
  • Tang G; Department of Ophthalmology, Shijiazhuang People's Hospital, Shijiazhuang 050030, China.
  • Yan X; Department of Ophthalmology, Shijiazhuang People's Hospital, Shijiazhuang 050030, China.
  • Lu L; Department of Ophthalmology, Fujian Medical University Union Hospital, Fuzhou, Fujian Province 350001, China.
  • Xiao M; Department of Ophthalmology, Fujian Medical University Union Hospital, Fuzhou, Fujian Province 350001, China.
  • Yuan H; Department of Ophthalmology, The 2nd Affiliated Hospital, Harbin Medical University, Harbin 150086, China.
  • Song W; Department of Ophthalmology, The 2nd Affiliated Hospital, Harbin Medical University, Harbin 150086, China.
  • Zhou M; Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai 200080, China.
  • Zhao X; Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai 200080, China.
  • Nie X; Department of Ophthalmology, Chongqing People's Hospital, Chongqing 401121, China.
  • Liao M; Department of Ophthalmology, Chongqing People's Hospital, Chongqing 401121, China.
  • Song Y; State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou 510060, China.
  • Wang Z; State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou 510060, China.
  • Chen W; State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou 510060, China.
  • Barton K; NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, UCL Institute of Ophthalmology, London, UK.
  • Park KH; Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea.
  • Aung T; Singapore National Eye Centre, Singapore Eye Research Institute, Singapore, Singapore.
  • Lam DSC; The International Eye Research Institute, The Chinese University of Hong Kong (Shenzhen), Shenzhen, China.
  • Weinreb RN; Hamilton Glaucoma Center, Viterbi Family Department of Ophthalmology, Shiley Eye Institute, University of California, San Diego, CA, USA.
  • Tham CC; Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Zeng L; Department of Ophthalmology, Chengdu First People's Hospital, Chengdu 610095, China.
  • Xie L; Department of Ophthalmology, the Third Affiliated Hospital of Chongqing Medical University, Chongqing 401120, China.
  • Wang N; Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
  • Zhang X; State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou 510060, China.
J Glaucoma ; 2024 May 21.
Article em En | MEDLINE | ID: mdl-38767510
ABSTRACT

PURPOSE:

To evaluate the impact of the extent of peripheral anterior synechiae (PAS) on the effectiveness and safety of combined phacoemulsification (PEI), goniosynechialysis (GSL), and goniotomy (GT) in eyes with primary angle-closure glaucoma (PACG) and cataract. PATIENTS AND

METHODS:

This study included patients diagnosed with PACG and cataract who underwent combined PEI and 120 degrees GSL plus GT (PEI+GSL+GT) between April 2020 and October 2022 at 10 ophthalmic institutes. Eligible patients were divided into three groups based on the extent of PAS 180°≤PAS<270°, 270°≤PAS<360°, and PAS=360°. Data on intraocular pressure (IOP), the number of ocular hypotensive medications, and complications were collected and compared. The study defined complete success as postoperative IOP within the 6-18 mmHg range and a 20% reduction from baseline without the use of topical medications. Qualified success was defined in the same way as complete success, but it allowed for the use of ocular hypotensive medications.

RESULTS:

Three hundred and four eyes of 283 patients were included. The mean follow-up was 12.50±1.24 months. All groups experienced a significant reduction in IOP after the surgery (P <0.05). There were no significant differences in final IOP, number of medications, and cumulative complete and qualified success rates among the three groups (P >0.05). The groups with 270°≤PAS<360°had a higher frequency of hyphema compared to 180°≤PAS<270° (P = 0.044).

CONCLUSIONS:

PEI+GSL+GT has proven to be an effective treatment for PACG with cataract over one year period. However, the outcome was not correlated with preoperative extent of PAS. PRCIS The combination of phacoemulsification, goniosynechialysis and goniotomy is an effective treatment for primary angle-closure glaucoma patients with cataract, and this is not linked to the extent of preoperative peripheral anterior synechiae.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article